Table 1. Clinical and biochemical characteristics of 20,920 participants.
| Men |
Women |
|||||
|---|---|---|---|---|---|---|
| Non-MetS | MetS | p value | Non-MetS | MetS | p value | |
| Participants | 6,132 | 2,678 | 10,719 | 1,391 | ||
| Age (years) | 59.1 (9.2) | 62.0 (8.2) | < 0.01 | 57.7 (9.4) | 62.0 (8.0) | < 0.01 |
| Body weight (kg) | 64.7 (9.4) | 73.3 (9.2) | < 0.01 | 53.7 (8.0) | 66.5 (9.4) | < 0.01 |
| BMI (kg/m2) | 23.5 (2.8) | 26.7 (2.7) | < 0.01 | 22.7 (3.1) | 28.6 (3.5) | < 0.01 |
| Waist circumference (cm) | 83.8 (7.8) | 93.0 (6.2) | < 0.01 | 80.6 (8.4) | 97.1 (6.3) | < 0.01 |
| SBP (mmHg) | 130.3 (15.3) | 138.5 (14.1) | < 0.01 | 126.5 (16.1) | 138.2 (14.8) | < 0.01 |
| DBP (mmHg) | 80.2 (10.0) | 83.9 (9.6) | < 0.01 | 76.4 (10.1) | 82.2 (9.8) | < 0.01 |
| Triglycerides (mg/dL) | 125.0 (93.3) | 160.9 (124.6) | < 0.01 | 99.7 (54.8) | 132.4 (67.4) | < 0.01 |
| HDL-C (mg/dL) | 57.6 (14.3) | 50.6 (13.4) | < 0.01 | 65.2 (15.1) | 57.0 (12.8) | < 0.01 |
| LDL-C (mg/dL) | 124.4 (32.4) | 125.1 (32.9) | 0.35 | 130.4 (32.3) | 130.5 (33.2) | 0.95 |
| FPG (mg/dL) | 97 (91–104) | 110 (99–124) | < 0.01 | 93 (88–100) | 104 (96–118) | < 0.01 |
| HbA1c (%) | 5.4 (0.7) | 6.0 (0.9) | < 0.01 | 5.4 (0.6) | 6.0 (0.9) | < 0.01 |
| Overweight (BMI ≥ 25) | 28.0 | 72.7 | < 0.01 | 21.4 | 87.6 | < 0.01 |
| Hypertension (%) | 45.7 | 79.3 | < 0.01 | 36.2 | 80.5 | < 0.01 |
| Dyslipidemia (%) | 51.4 | 80.6 | < 0.01 | 54.3 | 83.7 | < 0.01 |
| Diabetes (%) | 8.8 | 32.3 | < 0.01 | 5.1 | 26.9 | < 0.01 |
Values are expressed as mean (standard deviation), except for FPG, which is reported as median (25–75 percentile).
MetS, metabolic syndrome; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density-lipoprotein-cholesterol; LDL-C, low-density-lipoprotein-cholesterol; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c.